Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 21/3/2019
SIETES contiene 92697 citas

<< anterior 21 a 40 de 273 siguiente >>
Presentar resultados
Seleccionar todas
21.Tiene citas relacionadas Cita con resumen
Trotta F, Da Cas R, Alegiani SS, Gramegna M, Venegoni M, Zocchetti C, Traversa G. Evaluation of safety of A/H1N1 pandemic vaccination during pregnancy: cohort study. BMJ 2014;348:g3361. [Ref.ID 98028]
22.Tiene citas relacionadas
Fell DB, Dodds L, McNeil S, MacDonald NE. H1N1 influenza vaccination during pregnancy. BMJ 2014;348:g3500. [Ref.ID 98025]
23. Cita con resumen
Spielmans GI, Kirsch I. Drug approval and drug effectiveness. Annual Review of Clinical Psychology 2014;214:741-66. [Ref.ID 97582]
25. Cita con resumen
Hawkes N. Spoof research paper is accepted by 157 open access journals. BMJ 2013;347:5. [Ref.ID 96373]
26. Cita con resumen
Schroll J. Deaths in trial should always be reported. BMJ 2013;347:26. [Ref.ID 96139]
27. Cita con resumen
Bjelakovic G, Nikolova D, Gluud C. Antioxidant supplements to prevent mortality. JAMA 2013;310:1178-9. [Ref.ID 96115]
28.Tiene citas relacionadas Cita con resumen
Doshi P, Dickersin K, Healy D, Vedula SS, Jefferson T. Restoring invisible and abandoned trials: a call for people to publish the findings. BMJ 2013;346:23-6. [Ref.ID 95962]
29.Tiene citas relacionadas Cita con resumen
Loder E, Godlee F, Barbour V, Winker M. Restoring the integrity of the clinical trial evidence base. BMJ 2013;346:7. [Ref.ID 95959]
30. Cita con resumen
Morden NE, Schwartz LM, Fisher ES, Woloshin S. Accountable prescribing. N Engl J Med 2013;369:299-302. [Ref.ID 95875]
31. Cita con resumen
Avorn J. Approval of a tuberculosis drug based on a paradoxical surrogate measure. JAMA 2013;309:1349-50. [Ref.ID 95234]
32.Tiene citas relacionadas
Doshi P, Jefferson T. The first 2 years of the European Medicines Agency's policy on access to documents: secret no longer. JAMA Intern Med 2013;173:380-2. [Ref.ID 95096]
33.Tiene citas relacionadas Cita con resumen
Steinbrook R. The European Medicines Agency and the brave new world of access to clinical trial data. JAMA Intern Med 2013;173:373-4. [Ref.ID 95095]
34. Cita con resumen
Khong TP, de Vries F, Goldenberg JSB, Klungel OH, Ronbison NJ, Ibáñez L, Petri H. Potential impact of benzodiazepine use on the rate of hip fractures in five large European Countries and the United States. Calcif Tissue Int 2013;91:24-31. [Ref.ID 94615]
35. Cita con resumen
Hitchings A, Baker E, Khong T. Making medicines evergreen. BMJ 2012;345:18-20. [Ref.ID 94206]
36. Cita con resumen
Holtzman NA. Chronicle of an unforetold death. Arch Intern Med 2012;172:1174-8. [Ref.ID 93591]
37.Tiene citas relacionadas Cita con resumen
Light D, Lexchin J. Pharmaceutical R&D. What do we get for all that money?. BMJ 2012;345:22-5. [Ref.ID 93566]
38.Tiene citas relacionadas Cita con resumen
Gale E. Post-marketing studies of new insulins: science or sales?. BMJ 2012;344:24-7. [Ref.ID 93248]
39. Cita con resumen
Diao D, Wright JM, Cundiff DK, Gueyffier F. Pharmacotherapy for mild hypertension. Cochrane Database of Systematic Reviews 2012:15 de agosto. [Ref.ID 93224]
40. Cita con resumen
Anónimo. Long-acting beta2 agonists for childhood asthma. Australian Prescriber 2012;35:111-3. [Ref.ID 93160]
Seleccionar todas
<< anterior 21 a 40 de 273 siguiente >>